Phase I trial of granulocyte - macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: A cancer and leukemia group B study Academic Article Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Clinical Trials as Topic
  • Neoadjuvant Therapy
  • Neoplasm, Residual
  • Practice Guidelines as Topic

abstract

  • Phase II studies of this intensive regimen in malignant diseases sensitive to alkylating agents are currently being done in CALGB.

publication date

  • August 1993

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1093/jnci/85.16.1319

PubMed ID

  • 8340944

Additional Document Info

start page

  • 1319

end page

  • 26

volume

  • 85

number

  • 16